Lombard Odier Asset Management (Europe)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Lombard Odier Asset Management (Europe)'s EW Position: Q3 2022 in Review
Lombard Odier Asset Management (Europe) sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 13,168 shares — an estimated $1.25M sold.
Lombard Odier Asset Management (Europe) first reported a position in EW in Q2 2016 and held it in 19 quarters. The position peaked at $1.25M in Q2 2022. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- Lombard Odier Asset Management (Europe) reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
- Lombard Odier Asset Management (Europe) sold 13,168 Edwards Lifesciences shares in Q3 2022, an estimated $1.25M.
- Lombard Odier Asset Management (Europe) first reported a position in Edwards Lifesciences in Q2 2016 and held it in 19 quarters.
- Lombard Odier Asset Management (Europe)'s Edwards Lifesciences position peaked at $1.25M in Q2 2022.
- 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2022, filed 14 Nov 2022.